Recent Gene Therapy Approvals and Their Preparations for Commercialization

InfoWeb Marketplace

Saturday, June 15, 2019Description :
Clive Glover, Strategic Director for Gene Therapy at Pall Biotech discusses the recent approvals for Zynteglo and Zolensma and how manufacturing investment has prepared for product commercialization. For more gene therapy updates, visit https://biotech.pall.com/en/blog.html

Grouped quotes (0)